Thus, the reduction in GM-CSF expression by SCD could lead to anti-inflammatory potential of inhibiting the NF-κB signaling pathway and reducing production of inflammatory biomarkers. This evidence concerns the gene CSF2 and Schnyder corneal dystrophy.